The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Patient details
Timeframe: collected at baseline
Tumor details
Timeframe: collected at baseline, first prospective treatment and follow-up
Symptoms
Timeframe: collected at baseline, first prospective treatment and follow-up
Treatment details - previous treatment of the index of the spine
Timeframe: Collected at baseline
Imaging information
Timeframe: collected at baseline, first prospective treatment, discharge and at follow-up.
Patient reported outcomes - Euroqol EQ-5D-3L / - EQ-5D VAS
Timeframe: collected at baseline, first prospective treatment, discharge and at follow-up.
Ambulation
Timeframe: collected at baseline, discharge and at follow-up.
Nutritional status tool
Timeframe: collected at baseline, first prospective treatment, discharge and at follow-up.
Morbidity data - Adverse events
Timeframe: collected at first prospective treatment, discharge and at follow-up.
Local disease recurrence data
Timeframe: collected at baseline and at follow-up.
Survival
Timeframe: collected at first prospective treatment, discharge and at follow-up.
Treatment details - Current treatment of the index target of the spine
Timeframe: collected at first prospective treatment and at follow-up.
Treatment details - Current treatment for the primary cancer
Timeframe: collected at baseline, first prospective treatment and at follow-up.
Patient reported outcomes - Pain Numeric Rating Scale
Timeframe: collected at baseline, first prospective treatment, discharge and at follow-up.
Patient reported outcomes - Spine Oncology Study Group Outcome Questionnaire (SOSGOQ)
Timeframe: collected at baseline, first prospective treatment, discharge and at follow-up.